STING1 and lung carcinoma: A previous report demonstrates that STING downregulation is generally observed in human lung cancer subtypes, including small-cell lung cancer, large-cell neuroendocrine lung cancer, LUAD and LUSC, in comparison to normal lung tissues [46].